Clinical Trials

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT04271410 2023-04-18

CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma

80 enrolled

Leukemia, Lymphoma, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04648475 2023-04-18

Safety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma

40 enrolled

Leukemia, B-Cell, Lymphoma, B-Cell

NCT04649983 2023-04-18

CD19 and CD22 Targeted CAR-T Cell Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma

40 enrolled

Leukemia, B-Cell, Lymphoma, B-Cell

NCT04782193 2023-04-18

a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

40 enrolled

Lymphoma, B-Cell

NCT05797948 2023-04-04

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Phase NA Unknown

Recurrence, Lymphoma, B-Cell

NCT05776407 2023-03-20

Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma

Lymphoma, B-Cell

NCT05755828 2023-03-06

Clinical Study of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell Lymphoma

30 enrolled

Lymphoma, B-Cell

NCT05744037 2023-02-24

Clinical Study of the Safety and Efficacy of the R/R B-NHL Regimen With BTK Inhibitor+Anti-CD19 CAR-T Cells

30 enrolled

Phase EARLY_PHASE1 Unknown

Lymphoma, B-Cell

NCT05739227 2023-02-22

Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting r/r B-cell Hematologic Malignancies

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05731375 2023-02-16

MUSCLE

Unknown

Lymphoma, B-Cell, Lymphoma, T-Cell

NCT05322330 2023-02-09

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

Lymphoma, B-Cell

NCT04887025 2023-02-06

Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Lymphoma

25 enrolled

Recurrence, Lymphoma, B-Cell

NCT05585996 2023-02-06

Exploratory Clinical Study of CD19-targeted CAR-T and CAR-DC in the Treatment of Relapsed and Refractory B-cell Lymphoma

70 enrolled

Recurrence, Lymphoma, B-Cell

NCT05667155 2023-02-06

Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

48 enrolled

Lymphoma, B-Cell

NCT05691153 2023-01-19

ThisCART19A for B-NHL Relapsed After Auto-CAR T

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT05651100 2022-12-14

Safety and Efficacy of Sequential CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma

50 enrolled

Lymphoma, Lymphoma, B-Cell

NCT05619861 2022-11-17

CAR-T Cells in the Treatment of Malignant Hematological Tumors

Phase NA Unknown

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, B-Cell, Leukemia, T-Cell, Lymphoma, B-Cell

NCT05415098 2022-11-16

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

GastrointestinalHead & NeckLymphoidOther solid neoplasmSarcomaThoracic

90 enrolled

Nasopharyngeal Carcinoma, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Stomach Neoplasms, Lymphoma, B-Cell

NCT04684472 2022-09-26

Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies

18 enrolled

Leukemia, Lymphoma, B-Cell

NCT05453669 2022-07-12

Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL

Lymphoma, B-Cell

NCT05385263 2022-05-26

Addition of Nivolumab to Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive DLBCL at Lymphodepletion

Lymphoma, B-Cell

NCT05379647 2022-05-18

Natural Killer (NK) Cell Therapy for B-Cell Malignancies

24 enrolled

Burkitt Lymphoma, Lymphoma, B-Cell

NCT05286164 2022-04-15

Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART

30 enrolled

Lymphoma, B-Cell

NCT04246359 2022-04-07

RIPPLE

52 enrolled

Lymphoma, B-Cell

NCT05312476 2022-04-05

Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma

Lymphoma, B-Cell

NCT03646422 2022-03-31

AEDV Registry of Primary Cutaneous Lymphoma

Unknown

2,000 enrolled

DermatologicLymphoid

Sezary Syndrome, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Extranodal NK-T-Cell

NCT05003141 2022-03-28

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

110 enrolled

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT05155839 2022-02-22

Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)

108 enrolled

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, B-Cell

NCT02481310 2022-02-21

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

38 enrolled 12 charts

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05164770 2021-12-21

Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Phase 3 Unknown

160 enrolled

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT04948788 2021-09-28

SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma

102 enrolled

Recurrence, Lymphoma, B-Cell

NCT05014100 2021-08-27

Orelabrutinib in Combination With R2 Regimen for R/R CD20+ B-cell Lymphoma

55 enrolled

Lymphoma, B-Cell

NCT04887012 2021-05-14

Clinical Study of HLA Haploidentical CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL

25 enrolled

Lymphoma, B-Cell

NCT04289220 2021-05-13

Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia

10 enrolled

Burkitt Lymphoma, Lymphoma, B-Cell

NCT04814004 2021-03-29

Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors

BreastGynecologicLymphoid

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03000192 2021-03-17

HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life

Unknown

3,000 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Vulvar Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Endometrial Neoplasms

NCT03245905 2021-03-16

Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHL

100 enrolled